Nabunya Proscovia, Ssewamala Fred M, Bahar Ozge Sensoy, Michalopoulos Lynn T M, Mugisha James, Neilands Torsten B, Trani Jean-Francois, McKay Mary M
International Center for Child Health and Development (ICHAD), St. Louis, USA.
Brown School, Washington University in St. Louis, Campus Box 1196, One Brookings Drive, St. Louis, MO, 63130, USA.
Pilot Feasibility Stud. 2022 Apr 29;8(1):95. doi: 10.1186/s40814-022-01055-7.
Sub-Saharan Africa (SSA) is heavily burdened by HIV, with 85% of the global new infections among adolescents happening in the region. With advances in medication and national policies promoting antiretroviral therapy (ART), children < 15 years living with HIV (CLWH) continue to grow with a chronic, highly stigmatized disease. Unfortunately, the stigma they experience results in much lower quality of life, including poor mental health and treatment outcomes. Family members also experience stigma and shame by virtue of their association with an HIV-infected family member. Yet, stigma-reduction interventions targeting CLWH and their families are very limited. The goal of this study is to address HIV-associated stigma among CLWH and their caregivers in Uganda.
This three-arm cluster randomized control trial, known as Suubi4Stigma, will evaluate the feasibility, acceptability, and preliminary impact of two evidence-based interventions: (1) group cognitive behavioral therapy (G-CBT) focused on cognitive restructuring and strengthening coping skills at the individual level and (2) a multiple family group (MFG) intervention that strengthens family relationships to address stigma among CLWH (N = 90, 10-14 years) and their families (dyads) in Uganda. Nine clinics will be randomized to one of three study arms (n = 3 clinics, 30 child-caregiver dyads each): (1) usual care; (2) G-CBT + usual care; and (3) MFG + usual care. Both treatment and control conditions will be delivered over a 3-month period. Data will be collected at baseline (pre-intervention) and at 3 months and 6 months post-intervention initiation.
The primary aim of the proposed project is to address the urgent need for theoretically and empirically informed interventions that seek to reduce HIV-associated stigma and its negative impact on adolescent health and psychosocial well-being. As several countries in SSA grapple with care and support for CLWH, this study will lay the foundation for a larger intervention study investigating how HIV-associated stigma can be reduced to foster healthy child development-especially for CLWH as they transition through adolescence.
ClinicalTrials.gov: NCT04528732 ; Registered August 27, 2020.
撒哈拉以南非洲地区(SSA)深受艾滋病病毒(HIV)的困扰,全球青少年新增感染病例中有85%发生在该地区。随着药物治疗的进步以及国家推广抗逆转录病毒疗法(ART)政策的实施,感染HIV的15岁以下儿童(CLWH)继续在慢性且备受歧视的疾病中成长。不幸的是,他们所遭受的歧视导致生活质量大幅下降,包括心理健康状况不佳和治疗效果欠佳。家庭成员也因其与感染HIV的家庭成员的关系而遭受歧视和耻辱。然而,针对CLWH及其家庭的减少歧视干预措施非常有限。本研究的目的是解决乌干达CLWH及其照料者中与HIV相关的歧视问题。
这项名为Suubi4Stigma的三臂整群随机对照试验,将评估两种循证干预措施的可行性、可接受性和初步影响:(1)以个体层面的认知重构和强化应对技能为重点的团体认知行为疗法(G-CBT);(2)一种强化家庭关系以解决乌干达CLWH(N = 90,年龄10 - 14岁)及其家庭(二元组)中歧视问题的多家庭团体(MFG)干预措施。九家诊所将被随机分配到三个研究组之一(n = 3家诊所,每组30个儿童 - 照料者二元组):(1)常规护理;(2)G-CBT +常规护理;(3)MFG +常规护理。治疗和对照条件将在3个月内实施。数据将在基线(干预前)以及干预开始后的3个月和6个月收集。
拟议项目的主要目标是满足迫切需求,即开展理论和实证依据充分的干预措施,以减少与HIV相关的歧视及其对青少年健康和心理社会福祉的负面影响。由于SSA的几个国家正在努力应对CLWH的护理和支持问题,本研究将为一项更大规模的干预研究奠定基础,该研究将调查如何减少与HIV相关的歧视以促进儿童健康发展,特别是对于正处于青春期过渡阶段的CLWH。
ClinicalTrials.gov:NCT04528732;于2020年8月27日注册。